Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) mean price target has been set at $23.00 by Thomson Reuters. The group worked out on the stock recommendations given by analysts in the First Call poll. Further, it is possible that the company may register per share earnings of $0.55 in the near-term quarter and $2.27 for the ongoing fiscal. The market cap of Sabra Healthcare REIT, Inc. was recorded at $1.51B after the stock closed at $23.20 in last trading day. What The Valuation Says? The price/earnings ratio is taken in the list of ratios that leads to a stock’s valuation. Commonly named as P/E ratio, it helps investors know where the company stands in the market. It is derived by dividing share’s latest price by per-share earnings. Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has a P/E ratio of 43.53. Investors can identify how the stock is doing in the market by estimating Price-to-Earnings Growth ratio. Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) PEG ratio sits at 4.12. A low PEG ratio offers an investment opportunity to the opportunistic traders and investors. In case a stock has a reading in between 0 and 1, it represents undervalued stock. A reading of 1 and 2 represents fairly priced stocks. Technical Perspective The technical analysis of Sabra Healthcare REIT, Inc. visibly illustrates that the 50-day MA of Sabra Healthcare REIT, Inc. is $21.31, and stock is trading 1.89 or +8.86% distant from $21.31. The 200-day MA is $20.16, and this price is $3.05 or +15.11% off from current level. Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) 52-week high is $27.66 and the 52-week low is $14.92. This represents that if the stock moves $-4.46 points up on the chart to make a 52-week high. But, if it declines $+55.50%, then the shares price can hit a new 52-week low.
1 Chart Pattern Every Investor Should Know